Therefore, the increase in FAS in synovial tissues of RA patients may be caused by the activation of the FAS-FASL pathway leading to increased FAS expression or by further activation of the inflammatory response in vivo during synovial destruction in RA, which requires further investigation. Here, FASLG is linked to rheumatoid arthritis.